Paper Details

  1. Home
  2. Paper Details

PET-adapted omission of radiotherapy in early stage Hodgkin lymphoma-a systematic review and meta-analysis.

Author: BorchmannPeter, EngertAndreas, KobeCarsten, SickingerMarie T, SkoetzNicole, von TresckowBastian

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Hodgkin lymphoma (HL) is a common cancer in young adults and is highly curable. Treatment for HL is being adjusted based on a scan called a PET scan, which is done during treatment. A negative PET scan indicates good response, while a positive scan means the treatment isn't working as well. This is leading to research on giving less or more aggressive treatment based on the PET scan results.
Paper Details　
Original Abstract of the Article :
Hodgkin lymphoma (HL) is one of the most common malignancies in young adults and one of the most curable cancers worldwide. With interim PET-scan, HL treatment is in the process of being modified: a negative or positive interim PET separates good and poor responders to initial therapy; therefore, de...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.critrevonc.2016.03.005

データ提供：米国国立医学図書館（NLM）

PET-Guided Treatment for Hodgkin Lymphoma: Navigating the Shifting Sands of Cancer Care

Hodgkin lymphoma (HL) is a type of cancer that affects the lymphatic system, a complex network of vessels and tissues that plays a vital role in the body's immune response. This study explores the use of positron emission tomography (PET) scans in guiding the treatment of early-stage HL, examining the potential for de-escalating therapy based on the results of interim PET scans. The researchers investigated the feasibility of omitting radiotherapy in good responders, seeking to optimize treatment and minimize long-term side effects.

PET-Guided Therapy: A Personalized Approach to Hodgkin Lymphoma Treatment

The study highlights the potential of PET scans in guiding the treatment of early-stage HL. Interim PET scans can effectively identify good responders to initial therapy, allowing for the de-escalation of treatment and the potential omission of radiotherapy in these patients. This personalized approach can minimize unnecessary treatment, reduce long-term side effects, and improve the quality of life for HL patients. The study underscores the growing importance of imaging-guided therapy in optimizing cancer treatment.

Personalized Medicine: A New Oasis in Cancer Care

This study offers a glimpse into the future of cancer care, where personalized treatment approaches based on individual patient response are becoming increasingly prevalent. The use of PET scans to guide HL treatment represents a promising step toward optimizing care and minimizing unnecessary treatment. The study encourages further research and development of personalized treatment strategies for HL and other cancers.

Dr.Camel's Conclusion

This study offers a beacon of hope in the vast desert of cancer research. The use of PET scans to guide treatment for early-stage HL holds immense potential for improving patient outcomes by minimizing unnecessary treatment and reducing long-term side effects. This research underscores the importance of personalized medicine and the ongoing quest for innovative treatment strategies to combat this challenging disease.

Date :
  1. Date Completed 2017-01-09
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

26971064

DOI: Digital Object Identifier

10.1016/j.critrevonc.2016.03.005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.